TSX open
Loading markets…
Stocks/TSX/GILD

Gilead Sciences CDR (CAD Hedged) (GILD : TSX)

Common Stock

$170.33

CAD

+135.98 (395.87%)

Last updated: 2026-11-02

Follow GILD

GILD

Gilead Sciences CDR (CAD Hedged)

Source:WealthAwesomeWealthAwesome
↑ $3.95 (12.97%)
30 day period
$28.97$31.68$34.40Sep 21Oct 13Nov 2

Performance

1 Day

+0.15%

1 Week

+7.77%

1 Month

+17.85%

YTD

+38.04%

Key Statistics

Market Cap

$174.33B

52W High

$35.23

52W Low

$23.55

P/E Ratio

-

50 Day MA

$30.37

200 Day MA

$28.35

Beta

-

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/2/2026$34.36$34.40$33.62$34.40$34.4012,249
10/30/2026$34.42$35.23$34.17$34.35$34.3527,548
10/29/2026$32.64$33.30$32.40$33.24$33.2413,461
10/28/2026$31.85$32.08$31.85$32.06$32.063,090
10/27/2026$31.71$31.97$31.42$31.95$31.954,698
10/26/2026$31.77$32.07$31.77$31.92$31.924,943
10/23/2026$31.52$31.56$31.41$31.41$31.411,305
10/22/2026$30.93$31.65$30.93$31.62$31.6215,559
10/21/2026$31.12$31.14$30.62$31.06$31.064,311
10/20/2026$31.42$31.46$31.21$31.43$31.431,822

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GILD's historical volatility

HistoricalForecast68%95%
C$24.49C$31.25C$38.01C$44.77C$51.53C$58.29TodayJun 24Aug 28Nov 2Dec 15Jan 28Mar 12

30-Day Vol

26.7%

Annualized

90-Day Vol

28.4%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$41.13

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$36.51C$33.30 – C$40.03
60 trading daysC$38.75C$34.02 – C$44.14
90 trading daysC$41.13C$35.06 – C$48.24

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Gilead Sciences CDR (CAD Hedged)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Financials

Revenue (TTM)
$0
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
4049.30%
EPS (Diluted)
0.00
Book Value
-

Classification

Sector
Health Care

Recent Dividends

$0.000$0.084$0.1672025-06-13: $0.16402025-09-15: $0.16332025-12-15: $0.16012026-03-13: $0.16702026-09-15: $0.1649Jun 25Dec 25Sep 26

$0.1649CAD

Ex: Sep 15, 2026

Pay: Oct 7

Quarterly

$0.1670CAD

Ex: Mar 13, 2026

$0.1601CAD

Ex: Dec 15, 2025

$0.1633CAD

Ex: Sep 15, 2025

$0.1640CAD

Ex: Jun 13, 2025

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About GILD

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
PNC-APostmedia Network Canada Corp$0.14+21.74%
RTGRTG Mining Inc$0.03+20.00%
SAUSt Augustine Gold and Copper Ltd$0.17+17.86%
EGLXEnthusiast Gaming Holdings Inc$0.04+16.67%
CWLCaldwell Partners International Inc$1.34+16.52%
SLTSaltire Capital Ltd.$2.44+16.19%
EAGREast Side Games Group Inc$0.07+15.38%
AMAPAmapá Minerals Holdings Inc.$0.86+13.16%

GILD.TO news timeline

2 articles covering GILD.TO, most recent first

Latest

Gilead Sciences CDR (CAD Hedged) (GILD.TO) pays CA$0.1649 today

•Investing